Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
Date:2/29/2012

/p>

58,987,854Balance Sheet Information:December 31, 2011(Unaudited)December 31, 2010**Cash, cash equivalents, interest receivableand short-term investment securities

$
39,470$
28,512Total assets

43,48832,114Accumulated deficit

(369,887)(341,764)Stockholders' equity

31,04723,248*   Amount less than one cent.

**  Condensed from audited financial statements
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
2. Keryx Biopharmaceuticals Announces Phase 2 Data for KRX-0401 (Perifosine) in Hodgkins Lymphoma Presented at ASH Meeting
3. Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting
4. Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
10. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
11. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Pharma Major Lupin ... participación en ZAO "Biocom" en Rusia bajo ciertas ... de Lupin en el mercado farmacéutico de Rusia ... colocándolo como uno de los 10 principales mercados ... más de una década, el mercado farmacéutico ruso ...
(Date:7/2/2015)... 2015 Leading organizations have increasingly started ... and market insights in internal market research studies. ... it is essential for executives to fully understand ... capture critical business-related insights. According to ... LLC, most benchmarked companies find it impossible to ...
(Date:7/2/2015)... SAN DIEGO , July 2, 2015 ResMed ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now ... patients. Kybella is a non-surgical method to dissolve fat cells and is ... to severe fat deposits under the chin, commonly known as a double chin. Dr. ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Path of Least Resistance: ... economic transformation associated with the U.S. economy over the past 40 years. The book ... use. In many ways, the book is a time capsule that chronicles the economic ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women’s Excellence in Wellness, ... Lake Orion location. The special consists of 2 months of unlimited classes for just ... Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
(Date:7/4/2015)... ... 2015 , ... When a hacker gains access to someone’s email account, it can lead to ... July 1st, the FTC issued a scam alert about a social engineering scam ... a password reset instigated by the hacker. All they have to do is click ...
(Date:7/3/2015)... , ... July 03, 2015 ... ... the sessions and speaker lineup for its 2015 Annual Conference , ... August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3
... scientists have found that chemicals used to line junk ... food and being ingested by people where they are ... Perfluorinated carboxylic acids or PFCAs are the breakdown products ... stain-repellant products ranging from kitchen pans to clothing to ...
... Nov. 8, 2010 A small amount of bleeding ... individuals, according to a UC Irvine study. Neurologist ... that cerebral microbleeds are highly prevalent in the aging ... hypertension or neurodegenerative diseases such as Alzheimer,s, as had ...
... , MONDAY, Nov. 8 (HealthDay News) -- Because ... bone loss, long missions may take a toll on crew ... lead investigator Dr. Shreyasee Amin, an associate professor at the ... in 28 U.S. space crew members (24 males, four females) ...
... to have joint pain from taking aromatase inhibitors (AIs) if ... at the American College of Rheumatology,s annual meeting, held Nov. ... to identify factors that increase the likelihood that a patient ... standard adjuvant therapy for post-menopausal breast cancer, can cause joint ...
... International experts and scientists will present new ... of stockpiled drugs to identifying unlabeled substances in ... the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences ... Association of Pharmaceutical Scientists (AAPS) Annual Meeting and ...
... Substandard and counterfeit versions of thirteen key antimalarial medicines ... Medicines Quality Monitoring surveillance program. Set up by the ... the U.S. Pharmacopeial Convention (USP) and the U.S. Agency ... the public and private sectors. It was established in ...
Cached Medicine News:Health News:Dangerous chemicals in food wrappers likely migrating to humans: U of T study 2Health News:Spending Months in Space May Cause Long-Term Bone Loss 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 3Health News:Substandard and counterfeit antimalarial drugs discovered in Ghana 2
... monomeric contrast medium for intravascular and body ... a decade of clinical experience and use ... proven to be a valuable part of ... departments.Results from large multicentre monitoring trials1-3 confirm ...
... MultiHance (gadobenate dimeglumine) is a paramagnetic ... is complexed with gadobenate, a chelating agent ... around the godolinium ion. It is salified ... is endowed with all the physico-chemical features ...
... U.S. in 1993 to provide contrast enhancement ... detect lesions of the brain, spinal cord, ... approval for adult body and high-dose CNS ... OMNISCAN comes in different sizes to accommodate ...
... When MAGNEVIST (gadopentetate dimeglumine) injection was ... revolutionary concept of contrast-enhanced magnetic resonance imaging ... agent for use in MRI. Today, the ... indications in CNS, head, neck and body. ...
Medicine Products: